Clinical study on 10 cases of pancytopenia selectively treated by cyclosporine a

This study was aimed to explore the effect and adverse reaction of cyclosporine A (CsA) in treatment of pancytopenia without reticulocyte decrease but with elevated LDH. 10 patients were selected according to our standards and were treated by CsA. The curative effect and adverse reaction of patients...

Full description

Saved in:
Bibliographic Details
Published inZhongguo shi yan xue ye xue za zhi Vol. 17; no. 4; p. 1047
Main Authors Qiu, Hong-Xia, Li, Jian-Yong, Xu, Ji, Lv, Xin, Xu, Wei, Zhang, Su-Jiang, Wu, Han-Xing, Shao, Jing-Zhang
Format Journal Article
LanguageChinese
Published China 01.08.2009
Subjects
Adolescent
Adult
Cyclosporine - therapeutic use
Female
Humans
Immunosuppressive Agents - therapeutic use
Male
Middle Aged
Pancytopenia - drug therapy
Treatment Outcome
Young Adult
Online AccessGet more information

Cover

More Information
Summary:This study was aimed to explore the effect and adverse reaction of cyclosporine A (CsA) in treatment of pancytopenia without reticulocyte decrease but with elevated LDH. 10 patients were selected according to our standards and were treated by CsA. The curative effect and adverse reaction of patients were evaluated by following up for 6 - 116 months. The effect of CsA in the maintenance treatment of AA patient with an obvious rise of LDH was illustrated by means of typical case. The results indicated that 10 patients had different diagnosis, but had similar clinical and laboratory characteristics. Among them, 9 patients showed a relatively good curative reaction to CsA. Treatment of 1 patient was stopped because of pneumonia tuberculosis. It is concluded that the elevated LDH without reticuleocyte decrease may be a biomarker to predict the curative reaction to CsA for patients with pancytopenia. Selectively treating pancytopenia with CsA can obtain a higher curative reaction and maintenance treatment with CsA
ISSN:1009-2137